August 16, 2022
It gives us great pleasure to announce that Randy Lumia has joined us as a full-time Vice President of Human Resources & Organizational Effectiveness. As many of you may already know, Randy Lumia has been supporting us for about a year assisting with HR and talent matters. During this period, we have continued to bring Randy […]
July 10, 2022
We are excited to announce that our CEO, Jack Garvey, has been selected by our partners QbDVision to join their newly formed board of advisors! Check out the LinkedIn excerpt below to learn more. LinkedIn Post QbDVision Taken from LinkedIn… “At QbDVision, we firmly believe that finding the right guides is just as important as […]
June 27, 2022
The CDMO and CMO relationships and the whole kind of business dynamic is critically important to the life sciences space. And particularly now with what I what I see, and I think we’ve discussed, an explosion in the biopharmaceutical space. So, there’s a lot of amazing science that’s going on in the bio, the biologic […]
April 26, 2022
I think the fundamental principle for all regulated industry. Whether it be the biopharmaceutical industry or medical devices, scientific concepts do not result in products for patients at the end of the day. And that journey, the journey is as important as the concept. The article below will elaborate on the journey companies can take […]
April 5, 2022
Risk is still an important issue, and the fundamental premise is that there is so much to do. With this important issue and ever-changing landscape, biopharmaceutical risk is constantly evolving and requires immediate attention. The science is so complex. The regulatory environment is so complex. The business operating environment is so complex that companies can’t […]
February 28, 2022
In this exclusive interview from BMWS, our CEO at Compliance Architects, Jack Garvey, will be expanding upon some of the most common biopharmaceutical issues and trends from executives in 2022. Jack was asked “What are some of the common issues and trends you are hearing from biopharmaceutical executives?”, during this interview Some of the matters […]
© 2009-2025 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.
